BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24081227)

  • 1. Interface between pharmacotherapy and genes in human obesity.
    O'Connor A; Swick AG
    Hum Hered; 2013; 75(2-4):116-26. PubMed ID: 24081227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting thermogenesis and related pathways in anti-obesity drug discovery.
    Clapham JC; Arch JR
    Pharmacol Ther; 2011 Sep; 131(3):295-308. PubMed ID: 21514319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Well-being of obese individuals: therapeutic perspectives.
    Chaput JP; Tremblay A
    Future Med Chem; 2010 Dec; 2(12):1729-33. PubMed ID: 21428796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-obesity drugs: a review about their effects and their safety.
    Derosa G; Maffioli P
    Expert Opin Drug Saf; 2012 May; 11(3):459-71. PubMed ID: 22439841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on obesity pharmacotherapy.
    Bray GA; Ryan DH
    Ann N Y Acad Sci; 2014 Apr; 1311():1-13. PubMed ID: 24641701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we need anti-obesity drugs?
    Hainer V; Hainerová IA
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():8-20. PubMed ID: 23280861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the risk of obesity: defining the role of weight loss drugs.
    Ling H; Lenz TL; Burns TL; Hilleman DE
    Pharmacotherapy; 2013 Dec; 33(12):1308-21. PubMed ID: 23712541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new role of pharmacotherapy for weight reduction in obesity.
    Fernstrom MH; Fernstrom JD
    Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term pharmacotherapy for obesity.
    Klein S
    Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent concepts of pharmacotherapy and bariatric surgery for childhood obesity: an overview.
    Gogakos A; Tzotzas TC; Krassas GE
    Pediatr Endocrinol Rev; 2009 Dec; 7(2):3-14. PubMed ID: 20118889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatment of obesity in cardiovascular disease.
    Charakida M; Finer N
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):93-104. PubMed ID: 22292446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Past, present and future of obesity pharmacotherapy].
    Fábryová L
    Vnitr Lek; 2010 Oct; 56(10):1058-64. PubMed ID: 21105452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents.
    Walter CP; Bleske BE; Dorsch MP
    J Clin Pharm Ther; 2014 Oct; 39(5):475-84. PubMed ID: 24924286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and challenges in anti-obesity pharmacotherapy.
    Bessesen DH; Van Gaal LF
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):237-248. PubMed ID: 28919062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug treatment of obesity in the cardiovascular patient.
    Charakida M; Tousoulis D; Finer N
    Curr Opin Cardiol; 2013 Sep; 28(5):584-91. PubMed ID: 23928924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies.
    Jackson VM; Price DA; Carpino PA
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1055-66. PubMed ID: 25000213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal weight-loss surgery: glimpses at the molecular level.
    Freudenberg JM; Rajpal N; Way JM; Magid-Slav M; Rajpal DK
    Drug Discov Today; 2013 Jul; 18(13-14):625-36. PubMed ID: 23266345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medications for weight reduction.
    Bray GA
    Med Clin North Am; 2011 Sep; 95(5):989-1008. PubMed ID: 21855704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier?
    Kennett GA; Clifton PG
    Pharmacol Biochem Behav; 2010 Nov; 97(1):63-83. PubMed ID: 20688100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.